Drug Related Products: Perrigo Company (NYSE:PRGO), Auxilium Pharmaceuticals (NASDAQ:AUXL), USANA Health Sciences (NYSE:USNA), Nature’s Sunshine Prod. (NASDAQ:NATR)

Allegan and Holland, announced it has launched the generic equivalent to Neptazane tablets. Perrigo Company (NYSE:PRGO) stock performance was 1.64% in last session and finished the day at $165.49. Traded volume was 1.11million shares in the last session and the average volume of the stock remained 1.44million shares. Perrigo Company (NYSE:PRGO) insider ownership is 0.20%.

Auxilium Pharmaceuticals Inc (NASDAQ:AUXL)’s stock had its “neutral” rating restated by Zacks in a research note issued on Friday. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) rose 1.37 percent to $29.61 Friday on volume of 617,303.00million shares. The intra-day range of the stock was $29.00 to $29.86. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) has a market capitalization of $1.47billion.

Health-related mega-network marketing suppliers Nu Skin Enterprises (NUS_) and Usana Health Sciences Inc. (NYSE:USNA). These companies have the capacity to cause losses for Herbalife investors. USANA Health Sciences, Inc. (NYSE:USNA)’s stock on Mar 14, 2014 reported a increase of 0.70% to the closing price of $72.27. Its fifty two weeks range is $44.47-$92.00. The total market capitalization recorded $1.00billion. The overall volume in the last trading session was 96,644.00million shares. In its share capital, USNA has 14.42million outstanding shares.

Nature’s Sunshine Products, (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today announced that it will report fourth quarter and full year 2013 financial results for the period ended December 31, 2013 on Monday, March 17, 2014 at 4:00 p.m. Eastern Time. On Friday, shares of Nature’s Sunshine Prod. (NASDAQ:NATR) advanced 1.42% to close the day at $15.73. Company return on investment (ROI) is 19.70% and its monthly performance is recorded as 2.68%. Nature’s Sunshine Prod. (NASDAQ:NATR) quarterly revenue growth is -12.47%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone